Aldeyra Therapeutics Reports Full-Year 2020 Financial Results and Recent Business Highlights
− Enrollment Completed in Phase 3 INVIGORATE Trial, with Top-Line Results Expected in the First
− Enrollment Completed in Phase 3 INVIGORATE Trial, with Top-Line Results Expected in the First